Journal
JOURNAL OF SURGICAL ONCOLOGY
Volume 101, Issue 4, Pages 334-343Publisher
WILEY
DOI: 10.1002/jso.21482
Keywords
ovarian cancer; neoadjuvant chemotherapy
Ask authors/readers for more resources
The current management of advanced ovarian cancer consists of aggressive primary cytoreductive surgery (PCS) followed by combination platinum based chemotherapy. Recent studies have suggested that platinum-based chemotherapy may be of benefit in patients with advanced ovarian cancer prior to cytoreductive surgery (neoadjuvant chemotherapy, NACT). The concept of NACT has not been completely validated in the treatment of ovarian cancer. This review will discuss the role of NACT in patients with advanced epithelial ovarian cancer. J. Surg. Oncol. 2010;101:334-343. (C) 2010 Wiley-Liss, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available